Global Blood Therapeutics
UEI: H4LLV5LPHA37
• CAGE: 75SU5
Overview
Parent Awardee
Name
Global Blood Therapeutics
Headquarters
South San Francisco, CA
United States
United States
Most Recent Award
March 14, 2023
Calculating
Federal contract recipient
GLOBAL BLOOD THERAPEUTICS, INC.
(UEI H4LLV5LPHA37, CAGE 75SU5)
is headquartered in South San Francisco CA.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in February 2011 and
federally registered in
June 2014.
Federal Award Analysis
Global Blood Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
GLOBAL BLOOD THERAPEUTICS, INC.
UEI
H4LLV5LPHA37
CAGE Code
75SU5
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Feb. 4, 2011
Initial Registration
June 25, 2014
Last Registration
Feb. 13, 2025
Registration Activation
Feb. 12, 2025
Registration Expiration
Feb. 10, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Manufacturer of Goods
Manufacturer of Goods
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Disaster Registry
Nationwide
Reported NAICS
Accepts Credit Cards
No
People
Vendor contacts at Global Blood Therapeutics
GSA Schedules and Price Lists
- Global Blood Therapeutics
- PoP: 7/14/20 - 12/31/23 (Ended)
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $176,907
- Global Blood Therapeutics
- PoP: 3/3/20 - 7/15/20 (Ended)
- Obligated: $0